Solventum Co. (NYSE:SOLV) Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC reduced its stake in Solventum Co. (NYSE:SOLV - Free Report) by 17.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,626 shares of the company's stock after selling 10,673 shares during the quarter. Commonwealth Equity Services LLC's holdings in Solventum were worth $3,278,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of SOLV. Modus Advisors LLC acquired a new stake in Solventum during the fourth quarter worth about $25,000. Stonebridge Financial Group LLC acquired a new position in shares of Solventum in the 4th quarter worth approximately $26,000. Crews Bank & Trust bought a new stake in shares of Solventum during the 4th quarter valued at about $32,000. True Wealth Design LLC increased its stake in Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company's stock valued at $33,000 after purchasing an additional 471 shares in the last quarter. Finally, Synergy Asset Management LLC acquired a new position in shares of Solventum during the fourth quarter worth approximately $35,000.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Wells Fargo & Company boosted their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a report on Friday, February 28th. Piper Sandler raised their price target on Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a report on Friday, February 28th. Morgan Stanley upped their target price on Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. Mizuho lifted their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. Finally, Bank of America lifted their target price on shares of Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Solventum currently has an average rating of "Hold" and an average price target of $79.86.

Remove Ads

Solventum Price Performance

Shares of NYSE:SOLV traded down $0.73 during midday trading on Friday, reaching $74.78. 1,933,229 shares of the company's stock traded hands, compared to its average volume of 1,475,014. The company has a market cap of $12.94 billion and a P/E ratio of 27.19. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $85.92. The company has a fifty day simple moving average of $75.51 and a two-hundred day simple moving average of $71.85. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.